Phathom Pharmaceuticals PHAT Q1 2026 Disappoints EPS 037 Below 033 Views MFS MCR Steady at 603 Awaiting Next Catalyst 20260514 Jumia JMIA Stock Analysis Falls 271 Watching 647 20260518 Women in Finance Leadership in India From Banking to Global Capability Centers GCCs Chubb Limited Draws Cautious Optimism from Wall Street Analysts VALE SA VALE Q1 2026 Results Trail Estimates A Deeper Look Lexeo Therapeutics LXEO Sees Mild Gains as Stock Holds Above Key Support Trump Postpones AI Executive Order Signing Cites Concerns Over Potential Regulatory Blockage Meta Settles Landmark US Lawsuit Over Youth Mental Health Costs Tied to School Districts Elon Musks OpenAI Attack Viewed as Competitive Strategy to Boost xAI Michael Saylor Tokenization Could Enable Yield Shopping Challenging Traditional Finance SpaceX Starship Test Flight Draws Investor Attention Ahead of Potential IPO Robins Nest Delays Ford F250 Sale A Lesson in Wildlife Protection Laws Tulsi Gabbards Resignation Adds to Cabinet Turnover in Trumps Second Term Nokia Q1 2026 Earnings EPS Beats Estimates by 2285 as Cost Discipline Drives Profitability CORT Q1 2026 Earnings Sharp EPS Miss Reflects Higher Costs and Absence of Revenue CRNX Q1 2026 Earnings NarrowerThanExpected Loss as Crinetics Advances Pipeline Haverty Furniture Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Higher ADPT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise UBS Maintains Buy Rating on Under Armour Amid Market Scrutiny CLBT Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response